The six species of the Bacteroides fragilis group are potent pathogens and commonly have different susceptibility patterns. We determined the relative annual isolation rate of anaerobic bacteria and the susceptibility of B. fragilis group species isolated during 1987 at two community hospitals. The 
Bacteroides fragilis is a well-known clinical pathogen that may be resistant to a variety of antimicrobial agents. In a nationwide survey, Tally et al. (24) noted regional differences in the susceptibility patterns of anaerobic bacteria and clustering of resistance at various hospitals. They therefore recommended that susceptibility studies should be performed on selected clinical isolates, especially of the B. fragilis group species, to monitor for outbreaks of infections caused by resistant organisms.
The B. fragilis group is composed of at least six bileresistant species (B. fragilis, B. distasonis, B. vulgatus, B. ovatus, B. thetaiotaomicron, and B. uniforms) and contains other B. fragilis group organisms whose species have not yet been determined (16) . The six species commonly have different susceptibility patterns (2, 26, 27 [20] [21] [22] . Adding to this complexity is the fact that numerous new antimicrobial agents with activity against anaerobic bacteria have become available.
Because of differences in patient populations and antimicrobial usage, it is difficult to extrapolate from the limited data available on the frequency of isolation of the various B. fragilis group species and the susceptibility of these individual species determined at foreign (6, 12, 14, 17, 19) and domestic (7, 15, 25, 27) research and tertiary care university hospitals to those situations encountered at community hospitals. Consequently, there are sparse data with which the many community clinicians may make rational therapeutic decisions.
In an effort to provide more information on pathogenic anaerobic organisms isolated at the community hospital, we collected all anaerobic bacterial isolates, except propionibacteria, and identified all B. fragilis group species isolated from clinical specimens at two community hospitals during 1987. We then compared the activities of cefoxitin, cefotetan, ceftizoxime, cefmetazole, clindamycin, imipenem, and piperacillin against 234 representative strains of the B. fragilis group.
MATERIALS AND METHODS
All anaerobic bacteria were isolated and identified according to standard criteria (16, 22 (7, 15, 22) . Recent surveys from Turkey (14) and India (4) had fewer B. thetaiotaomicron isolates and more frequent isolation of B. ovatus. This may reflect the similarity of these two organisms and the difficulty in separating these species. We used fermentation of xylan to separate B. ovatus from B. thetaiotaomicron. cefotetan and cefmetazole. At a breakpoint of 32 ,ug/ml, 92% pulmonary abscesses (22) . Because of their ability to proof B. thetaiotaomicron isolates were susceptible to cefoxitin duce ,-lactamases, inactivating many common antimicrobial compared with 29% to cefmetazole and only 24% to cefoteagents, and their particular ability to produce abscesses, tan. For B. ovatus isolates, 82% were susceptible to cefoxmembers of the B. fragilis group are considered the most itin but only 15% to cefmetazole and 12% to cefotetan. For important anaerobic pathogens (10) . The designation of six B. uniforms isolates, 78% were susceptible to cefoxitin separate species in the B. fragilis group has necessitated a compared with 58% to both cefotetan and cefmetazole-In revised look at the frequency of isolation, pathogenicity, and general, ceftizoxime was less active, with 75% of B. fragilis, antimicrobial susceptiNlity of each species (7 15, 26 (12) 32 (16) 63 (22) 34 (21) 19 (6) 4-128 0. 5 (8) 63 (8) 39 (8) 72 (0.5) 100 (4) 86 (16) 21 (8) 79 (8) 86 (8) 72 (8) 86 (0.5) 100 (4) 72 (16) 0 (8) 3 (8) 13 (8) 63 (8) 44 (0.5) 97 (4) 69 (16) 8 (8) 8 (8) 10 (8) 6 (8) 18 (0.5) 100 (4) 30 (16) 3 (8) 0 (8) 9 (8) 9 (8) 41 (0.5) 100 (4) 47 (16) 47 (8) 16 (8) 53 (8) 16 (8) 42 (0.5) 100 (4) 53 (16) 84 (16) 93 (16) 84 (16) 49 (16) 91 (4) 100 (8) 88 (32) 84 (16) 86 (16) 90 (16) 83 (16) 93 (4) 100 (8) 72 (32) 6 (16) 6 (16) 28 (16) 66 (16) 94 (4) 100 (8) 72 (32) 10 (16) 11 (16) 32 (16) (8) 79 (64) " Number in parentheses is breakpoint.
reports of Brook (7) and Sutter et al. (22) , we found that peptostreptococci were the second most frequently isolated group of anaerobic bacteria. Intra-abdominal infection was the most common source for all anaerobic organisms and accounted for 42% of isolates. A total of 8% of isolates were from blood cultures. B. fragilis and B. thetaiotaomicron accounted for 53% of blood isolates, while B. distasonis, B. ovatus, B. vulgatus, and B. uniformis were infrequently isolated from blood. This is in accord with the results of Brook (7) and Heseltine et al. (15) , who noted frequent isolation of B. fragilis and B. thetaiotaomicron, but rarely the other B. fragilis group species, from the blood. Brook (submitted for publication) reported that the mortality associated with bacteremia caused by B. fragilis (24%) and B. ovatus (20%) at Walter Reed Army Hospital was much lower than that for the bacteremia caused by B. thetaiotaomnicron (38%), B. vulgatus (40%), and B. distasonis (50%). He speculated that the increased mortality might be related to the broader antimicrobial resistance pattern of those species, as was seen with our isolates (Table 5) . In most series, including the current study, Clostridium species were also frequent blood isolates.
Community hospital clinical laboratories may not always isolate and identify all strains in multibacterial infections. However, the relative frequency of isolation of each member of the B. fragilis group species was similar to those reported from American university and research hospitals (Table 3) (7, 15, 22) . One study from Turkey (14) and one from India (4) had results that were generally similar to those of American studies except for a lower frequency of B. thetaiotaomicron and a higher rate for B. ovatus isolation. Again, this might be due to differences in media, isolation, and identification techniques used, or it could be due to differences in diet or the demographics of the populations studied.
Imipenem was the only agent tested with consistently good activity against virtually all isolates from all species of the B. fragilis group. Other studies (9, 17, 25) have also noted the excellent activity of imipenem against almost all isolates of all B. fragilis group species.
B. fragilis and B. vulgatus were generally equally susceptible to all other agents tested with the exception of ceftizoxime. A total of 25% of B. fragilis and 17% of B. vulgatus isolates were resistant to ceftizoxime at 32 ,ug/ml. B. thetaiotaomicron strains were generally resistant to cefmetazole, cefotetan, and ceftizoxime but susceptible to cefoxitin, clindamycin, and piperacillin. A similar pattern was seen with B. ovatus and B. uniforms strains. B. distasonis strains were also generally resistant to cefotetan and cefmetazole but susceptible to cefoxitin, clindamycin, and surprisingly, ceftizoxime. Cornick et al. (8) also noted cefmetazole to be less active than cefoxitin against B. fragilis, B. thetaiotaomicron, and B. ovatus isolates.
For a number of the strains tested, MICs were within one dilution of the breakpoint (clustering) for many of the agents tested. Table 5 shows the percentage of isolates susceptible to the various antimicrobial agents at several breakpoints, to allow clinicians to note any possible alterations that might occur when less than maximum dosage is used for therapy or to take into account the variability potentially resulting from such clustering.
Regardless of the method used for testing, cefotetan appeared to be consistently less active than cefoxitin. Andrews and Greenwood (3) studied eight B. fragilis group isolates that hydrolyzed cefoxitin and noted that cefotetan was less active than cefoxitin since ,-lactamase enzyme extracts degraded cefotetan more rapidly than cefoxitin. Our results with a supplemented brucella agar dilution method are in accord with those of Aldridge et al. (2) , who used a microdilution method with Anaerobe Broth (Difco), a formulation of Wilkins-Chalgren agar minus the agar, and noted that cefoxitin had better activity than cefotetan against all Bacteroides species tested, including those of the B. fragilis group. O'Keefe et al. (18) , using the NCCLS WilkinsChalgren agar dilution method, reported that cefotetan was equivalent to cefoxitin against B. fragilis species isolates, but less active against other B. fragilis group species.
Controversy surrounds the degree of in vitro activity of ceftizoxime against B. fragilis group species. The widely varying results have been attributed by Aldridge and Sanders (1) and Wexler and Finegold (26) to methodologic differences. Aldridge and Sanders (1) compared the activity of various beta-lactam agents and found "antibiotic and method-dependent" differences, with ceftizoxime showing the greatest number of variations and discrepancies in susceptibility interpretation among the cephalosporins tested. Using the NCCLS agar dilution method, O'Keefe et al. (18) noted ceftizoxime to have a lower geometric mean MIC than cefoxitin against B. fragilis group species. Aldridge and Sanders (1) reported that ceftizoxime was more active against B. distasonis than was cefoxitin. Drulak and Chow (11), using Wilkins-Chalgren agar and an agar dilution method, also noted ceftizoxime to be more active than cefoxitin against B. distasonis. However, the MIC%0s of cefoxitin and ceftizoxime were 16 and 32 ,ug/ml, respectively, against 31 strains of B. fragilis. This is in contrast to our data and to those of Sutter et al. (22) (23, 28) , the control strain of Clostridium perfringens gave inconsistent results when exposed to cefoperazone, and no MIC could be recommended. The control strains of B. thetaiotaomicron and C. perfringens gave inconsistent results when exposed to moxalactam in microdilution procedures, and no MICs could be recommended. Aldridge 
